Search for a report

NORTH AMERICA CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

NORTH AMERICA CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

The North America cartilage degeneration market is anticipated to register a CAGR of 4.80% over the estimated years of 2021 to 2028. The market growth of the region is mainly accredited to the rising prevalence of obesity due to imbalanced food fortification and unhealthy lifestyles, the well-established presence of numerous companies, and increased funding for product innovation.

NORTH AMERICA CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

North America Cartilage Degeneration Market by Procedure (Joint Replacement, Chondroplasty, Cell-based Cartilage Resurfacing, Osteochondral Transplant, Meniscus Transplants, Other Procedures) Market by Application (Knee, Hips, Other Applications) Market by End-user (Ambulatory Surgical Centers, Hospitals & Specialty Clinics, Academic & Research Institutes) by Geography

Request free sample

The North America cartilage degeneration market is anticipated to register a CAGR of 4.80% over the estimated years of 2021 to 2028. The market growth of the region is mainly accredited to the rising prevalence of obesity due to imbalanced food fortification and unhealthy lifestyles, the well-established presence of numerous companies, and increased funding for product innovation.north-america-cartilage-degeneration-market

To learn more about this report, request a free sample copy

The North America cartilage degeneration market growth evaluation includes the assessment of the United States and Canada. The United States holds a substantial share within the region’s cartilage degeneration market. The country’s market is primarily fueled by the increasing prevalence of arthritis, the surging number of sports injuries, and the rising geriatric population.

On the other hand, the significant increase in the aging populace in Canada is set to fuel the demand for procedures associated with cartilage degeneration. According to the estimations provided by Statistics Canada, the elderly are expected to equate to nearly 23% to 25% of the country’s total population by 2036. Besides, this percentage is likely to increase up to 28% by the year 2061. As a result, these factors are expected to play a vital role in augmenting the cartilage degeneration market growth in North America during the forecasting period.

CONMED Corporation is a medical technology firm engaged in providing surgical equipment and devices for minimally invasive procedures. The company’s product lines comprise general surgery and orthopedic surgery. The orthopedic surgery segment includes sports medicine instrumentation, ample bone, small bone, and specialty powered surgical instruments, as well as imaging systems. Its products are sold in more than 100 nations through its distributors and subsidiaries.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SPORTS INJURIES DAMAGING CARTILAGE AND LIGAMENTS
        • DEGENERATION OF CARTILAGE DUE TO OBESITY
        • BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
      • KEY RESTRAINTS
        • HIGH COST OF CARTILAGE REPAIR THERAPIES
        • LACK OF FAVORABLE REGULATORY ENVIRONMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYERS POWER
        • SUPPLIERS POWER
        • COMPETITIVE RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    3. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    4. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ANIKA THERAPEUTICS INC
        • ARTHREX INC
        • B BRAUN MELSUNGEN AG
        • BIOTISSUE SA
        • CARTIHEAL INC
        • CONMED CORPORATION
        • DEPUY SYNTHES COMPANIES
        • OSIRIS THERAPEUTICS INC
        • RTI SURGICAL INC
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • VERICEL CORPORATION
        • ZIMMER BIOMET HOLDINGS

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – CARTILAGE DEGENERATION

    TABLE 2: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN THE NORTH AMERICA CARTILAGE DEGENERATION MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020

    FIGURE 6: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020

    FIGURE 13: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020

    FIGURE 17: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 21: UNITED STATES CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: CANADA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    2. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    3. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now